BD to Present at Barclays 28th Annual Global Healthcare Conference

BD to Present at Barclays 28th Annual Global Healthcare Conference

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026 at 8:30 am Eastern Time.

The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.

About BD
BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X @BDandCo or Instagram @becton_dickinson.

Contacts:


Media

Investors:

Matt Marcus
VP, Public Relations
Matt.Marcus@bd.com 

Shawn Bevec

SVP, Investor Relations

Investor.Relations@bd.com 

 

Cision View original content:https://www.prnewswire.com/news-releases/bd-to-present-at-barclays-28th-annual-global-healthcare-conference-302694898.html

SOURCE BD (Becton, Dickinson and Company)

News Provided by PR Newswire via QuoteMedia

BDX
The Conversation (0)
Red Mountain Mining

Acquisition of “Thompson Falls” High-Grade Antimony Project Adjacent to America’s only Antimony Smelter

Red Mountain Mining Limited (ASX: RMX, US CODE: RMXFF, or “Company”), a Critical Minerals exploration and development company with an established portfolio in Tier-1 Mining Districts in the United States and Australia, is pleased to announce the Company’s newly-acquired Thompson Falls Antimony... Keep Reading...
Bcal Diagnostics Limited

BCAL Diagnostics Launches BREASTEST plus - Generating First Revenues

BCAL Diagnostics Limited (ASX: BDX) (“BCAL” or “the Company”), an Australian and US-based biotechnology company pioneering non-invasive breast cancer diagnostics, is pleased to announce the commercial launch of BREASTEST plus™. This first-in-class blood test is available from Thursday, 27 March... Keep Reading...
Bcal Diagnostics Limited

BCAL Commences US Operations

BCAL Diagnostics Limited (ASX: BDX) (“BCAL” or “the Company”) is pleased to announce that it has established a North Carolina, United States of America, incorporated wholly owned subsidiary, BCAL Diagnostics, Inc. (“BCAL US”) which will commence operations on 2 September 2024.... Keep Reading...
TSXV:SYH

Skyharbour Signs Option Agreement with Black Shield Metals Corp to Option 75% of the Mann Lake Uranium Project

Skyharbour Resources Ltd. (TSX-V: SYH ) (OTCQB: SYHBF ) (Frankfurt: SC1P ) ("Skyharbour" or the "Company") is pleased to announce that it has entered into an option agreement (the "Option Agreement") with Black Shield Metals Corp. (CSE: BDX) ("Black Shield") which provides Black Shield an... Keep Reading...
vegn stock cse

CSE Reports April 2021 Market Statistics

CSE is increasingly the exchange of choice for successful entrepreneursThe Canadian Securities Exchange ("CSE" or "the Exchange") today announced its market statistics for the month of April 2021. Trading volume exceeded three billion shares, while the total capital raised by issuers exceeded $1... Keep Reading...

Interactive Chart

Latest Press Releases

Related News